Analytics

The Analytics API combines selected data from the Investigational Drugs, Clinical and Patents APIs in a format suitable to enable graphical analysis in tools like Microsoft Excel, TIBCO Spotfire, Tableau Software or QlikView.

It enables extraction of data on trials, drug pipelines, patents and adverse events using 10 pre-defined functions. Additional details can be obtained for trials using the 2 references calls.

Analytics API can help you to

  • Import information into specific analysis tools, allowing precise manipulation of the data to display exactly what is required
  • Build visual dashboards, instantly displaying at a glance a candidate's progression through trials
  • Compare aggregated trial adverse events between drugs to evaluate their safety profile

Content

  • Development history data for drug candidates, specifically each combination of development phase, country, indication and organization
    • Ci view – Action | AuthorityGroup | Company | Country | Drug | EntityType | HighestDevStatus | HighestDevStatusForInd | Indication | IsActiveCompany | LatestChange | ParentCompany | Status | StatusDate | StatusSortCode | TherapyArea
  • Patent applications, specifically each combination of patent status, country, indication and organization
    • Patents view – Action | AuthorityGroup | Company | CompanyOwnershipRelationship | Country | Drug | DrugRelationship | EntityType | HighestPatStatus | HighestPatStatusForCnty | HighestPatStatusIdForCnty | Indication | LatestChange | ParentCompany | Patent | Status | StatusDate | StatusSortCode | TherapyArea
  • Trial information as data points or as summaries limited to trials with outcomes
    • Trial program view – Ancestry | ArmCount | DevStatus | Drug | Endpoint | EndpointReached | HasHealthyVolunteers | HighestDevStatusForInd | Indication | ProtocolAcronym | ProtocolTitle | Sponsor | StudyType | Trial id | TrialStartDate | TrialStatus
    • Trial program refs view – AdverseSummary | Description | DevStatus | Indications | OutcomeSummary | ProtocolTitle | References | TreatmentSummary | Trial id | TrialStatus
    • Trial duration refs view – ArmCount | Biomarkers | Condition | Controls | DevStatus | Drug | EnrollmentCount | Interventions | # of Patients | ProtocolAcronym | ProtocolTitle | Reference | Sponsor | Trial id | TrialStartDate | TrialStatus
    • Trial duration view – DevStatus | Drug | Endpoint | Indication | OriginatorSponsored | # of Patients | ProtocolTitle | Trial id | TrialEndDateActual | TrialEndDateCalc | TrialEndDateEstimate | TrialEndDateGiven | TrialStartDate | TrialStatus
  • Trial adverse events information as data points or as summaries limited to trials with outcomes
    • Trial safety view – AdverseEvent | AdverseIndicationCode | DevelopmentStatus | Dose | Drug | Intervention | MeddraAdverseEvent | Patients | PercentAffected | ProtocolDose | Trial id | Units
    • Trial safety refs view – AdverseSummary | Description | DevStatus | Drugs | Indications | OutcomeSummary | ProtocolTitle | References | TreatmentSummary | Trial id | TrialStatus
Demos 

A competitive intelligence matrix for drugs.

APIs involved in this demo: Analytics API with possible links to Investigational Drugs API to access drug details.

Cortellis Labs Terms & Conditions

The following terms govern your use of Cortellis Labs apps:

  1. Clarivate Analytics does not provide support for Cortellis Labs apps. We suggest you direct any questions regarding your use be directed to the discussion groups.
  2. THIS SITE IS PROVIDED BY CLARIVATE ANALYTICS ON AN "AS IS" AND "AS AVAILABLE" BASIS. CLARIVATE ANALYTICS MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, AS TO THE OPERATION OF THIS SITE, OR THE INFORMATION, CONTENT OR MATERIALS INCLUDED ON THIS SITE. YOU EXPRESSLY AGREE THAT YOUR USE OF THIS SITE IS AT YOUR SOLE RISK.
  3. The privacy notice applies to your use of Cortellis Labs apps, including our use of Google Analytics for site optimization and demo usage statistics.